GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement

2018-10-09 Last updated : 2019-07-12 GenAhead Bio Inc.

GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement.

　→ Press Release

Categories
News
Previous article
We will be an exhibitors at Bio Japan 2018.
2018-10-01
Next article
Our article was posted on The Chemical Daily.
2018-10-10